This filing reports on the ownership of Beamr Imaging Ltd. ordinary shares by Tamar Shoham, the Chief Technology Officer. The report details various stock options held by Shoham, including their exercise dates, expiration dates, and conversion/exercise prices. Some options have specific vesting schedules, with a portio...

This document is a Form 3 filing for Sharon Carmel, reporting initial beneficial ownership of Beamr Imaging Ltd. (BMR) ordinary shares. Ms. Carmel, who is identified as an officer (Chief Executive Officer) and a ten percent owner, acquired 3,568,190 ordinary shares. The filing indicates direct ownership of these shares...

This filing is an initial report of beneficial ownership for Danny Megrelishvili, Chief Product Officer at Beamr Imaging Ltd. (BMR). As of March 18, 2026, Megrelishvili directly holds 12,000 ordinary shares. Additionally, he holds options to purchase 245,274 ordinary shares, with 199,284 options currently vested and ex...

This filing reports initial ownership of securities by Lluis Pedragosa, a director at Beamr Imaging Ltd. (BMR). The report details holdings of stock options, including their exercise and expiration dates, underlying securities, and conversion prices. Specifically, Pedragosa holds options to purchase 19,000 ordinary sha...

This filing details a Form 3 for Beamr Imaging Ltd. (BMR), reporting ownership by Michael Ozeryansky, VP R&D. As of March 18, 2026, Ozeryansky holds options to purchase 50,000 ordinary shares, with 31,250 currently vested and exercisable. The remaining options vest in installments starting May 20, 2026, subject to cont...

This filing details Yair Shoham's initial ownership of securities in Beamr Imaging Ltd. (BMR). Shoham, a director, holds options to purchase ordinary shares with exercise prices of $4.00 and $1.65. The options have varying vesting and expiration dates, with some subject to continued service and others qualifying for ta...

This Form 3 filing details the ownership of securities by Osnat Michaeli, a director at Beamr Imaging Ltd. (BMR). The filing indicates that Michaeli directly holds options to purchase ordinary shares. Specifically, there is one set of options with an exercise price of $4.00, expiring on February 27, 2033, covering 19,0...

This filing is an initial report of beneficial ownership of securities for Daniel Sandler, the Chief Financial Officer of Beamr Imaging Ltd. (BMR). As of March 18, 2026, Sandler directly owns options to purchase a total of 130,000 ordinary shares. These options have varying exercise dates, expiration dates, and exercis...

This is a Form 3 filing by Liao Jia He, a director of Big Tree Cloud Holdings Ltd (ticker: DSY), reporting no securities ownership in the company as of March 18, 2026. The filing indicates that Liao Jia He, who resides in Fengtai District, China, holds a director position but does not own any securities of the company....

This filing reports initial ownership of Class A ordinary shares and restricted share units by Hong Weili, who is a director at BingEx Ltd. The ownership is direct. The filing details 9,978 Class A ordinary shares. Additionally, it covers 15,000 restricted share units, which are contingent rights to receive Class A ord...

This filing details the ownership of BingEx Ltd (FLX) by Liu Jing, who is a director at the company. The filing reports 9,978 shares of Class A ordinary shares, directly owned. Additionally, it discloses 15,000 restricted share units (RSUs) granted on November 26, 2024. These RSUs are convertible into Class A ordinary ...

This Form 3 filing reports the initial beneficial ownership of Haibo Ru, a director of BingEx Ltd (ticker: FLX). The filing discloses Ru's indirect ownership of Class A ordinary shares through two entities: Halfmoon Pavilion BeingEx Limited (holding 5,577,058 shares) and Black Opal BeingEx Limited (holding 3,981,294 sh...

Tang Le, Chief Financial Officer of BingEx Ltd, reported a change in beneficial ownership of company securities on March 18, 2026. The transaction involved the acquisition of 749,952 Class A ordinary shares, acquired upon vesting of restricted share units. Additionally, Mr. Le holds options to purchase 100,000 Class A ...

This filing reports the initial statement of beneficial ownership for Peng Xue, Chief Executive Officer and Director of BingEx Ltd. The report details holdings in Class B ordinary shares. Xue Peng directly owns 41,596,484 shares through Snoweagle-s Limited and 3,981,294 shares through Diamondbird-s Limited. The filing ...

This Form 3 filing discloses the initial statement of beneficial ownership by Zhihui Yang, a director of BingEx Ltd (ticker: FLX). The filing reports that Yang owns 14,763 Class A ordinary shares directly. Additionally, Yang holds 24,000 restricted share units that were granted on November 26, 2024, which represent the...

This filing reports initial ownership of BingEx Ltd (ticker: FLX) by Yu Hongjian, identified as Executive President and Director. The report details holdings in Class A ordinary shares and Restricted Share Units (RSUs). Yu Hongjian directly holds 1,499,931 Class A ordinary shares, acquired upon vesting of RSUs. Additio...

This filing details the ownership of BioLineRx Ltd. (BLRX) by Mali Zeevi, the Chief Financial Officer. The report includes information on stock options granted under the 2003 Amended and Restated Share Incentive Plan, with various grant and vesting dates. Specifically, it lists 8 separate option grants with exercise da...

This filing details the equity holdings of Annemarie Hanekamp, Chief Commercial Officer of BioNTech SE. It includes information on stock options and performance share units granted to her, with specific exercise dates, expiration dates, and underlying security details. The filing also contains a Limited Power of Attorn...

This filing relates to a Limited Power of Attorney granted by Dr. Ulrich Wandschneider, a director of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. The attorneys-in-fact are authorized to submit necessary forms and applications to the U.S. Securities and Exchange Commission (SEC) on behalf of ...

This filing details a Limited Power of Attorney granted by Dr. Ozlem Tureci, Chief Medical Officer of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. This grants them the authority to act on her behalf for all SEC reporting obligations, including filing forms such as Form ID, passphrase updates,...

This filing details a Limited Power of Attorney granted by Helmut Jeggle, a director of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. This power of attorney authorizes the appointed individuals to act on Jeggle's behalf for all SEC reporting obligations, including submitting applications for E...

This filing details the power of attorney granted by Sierk Poetting, Chief Operating Officer of BioNTech SE, to specific individuals for handling SEC reporting obligations. It outlines the authority granted to these attorneys-in-fact to submit applications for SEC access, take necessary actions for the undersigned, exe...

This filing details a Limited Power of Attorney granted by Michael Motschmann, a director of BioNTech SE, to Zoey Neuenschwander, Stefanie Lutze, and Humza Bokhari. The attorneys-in-fact are authorized to act on behalf of Mr. Motschmann for all SEC reporting obligations, including submitting applications for EDGAR acce...

This filing pertains to a Power of Attorney granted by Simon Turton to various individuals, including Stephen Stamp (CEO of Biodexa Pharmaceuticals Plc), Fiona Sharp (CFO), and legal representatives from Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. The attorneys-in-fact are authorized to prepare and execute SEC ...

This filing details a Power of Attorney granted by Fiona Mary Powell, Chief Financial Officer of Biodexa Pharmaceuticals Plc, to Stephen Stamp and others. The attorneys-in-fact are authorized to prepare and execute necessary documents for electronic filings with the SEC, manage the EDGAR system account, obtain informat...